I keep a written log of every draw with date, volume and syringe type.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
So which one, and on what grounds?
0.9 per cent is 9 mg of sodium chloride per millilitre — 0.9 g in 100 mL — which works out at about 154 mmol/L of each ion and is why it is called isotonic. Two things change relative to water for injection. Ionic strength: 154 mmol/L of salt is not nothing near a peptide's isoelectric point, where added ions can either salt it in or drop it out, and the direction is sequence-specific rather than general. Preservative: plain 0.9 per cent sodium chloride has none, so it is a single-use diluent, and a vial reconstituted in it does not get the twenty-eight days that a bacteriostatic diluent is conventionally given. Neither is a reason to avoid it. Both are reasons to write which diluent you used on the vial, because the two look identical afterwards.
This is not exotic. It is just the difference between doing it deliberately and doing it approximately.
Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.
| Appearance | Interpretation | Action |
|---|---|---|
| Intact opaque puck, proud of base | Cycle ran correctly | Proceed |
| Slumped to one side | Shipped before fully dry, or vibration | Usually usable; note it |
| Glassy translucent film | Collapse above glass transition | Test before use |
| Melt-back ring at stopper | Thermal excursion in transit | Test before use |
| No visible cake at all | Very low fill, or nothing there | Weigh it; query the supplier |
Do not use the same needle to pierce the stopper and to administer.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
edited 7 Apr 2025 by nominal_ten — updated for the 2026 guidance change
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsSodium chloride 0.9 per cent as a diluent is not a neutral substitution. Ionic strength affects peptide solubility and aggregation propensity.
The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
One limitation: technique reduces risk, it does not remove it.
Do the arithmetic twice, ideally with someone else doing it independently.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.